Viewing Study NCT01719250

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:14 PM
Ignite Modification Date: 2026-01-25 @ 4:19 AM
Study NCT ID: NCT01719250
Status: COMPLETED
Last Update Posted: 2018-10-09
First Post: 2012-10-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Sponsor: Mayo Clinic
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Adult Diffuse Large Cell Lymphoma View
None Recurrent Grade 3 Follicular Lymphoma View
None Recurrent Mantle Cell Lymphoma View
None Refractory Mantle Cell Lymphoma View
None Transformed Recurrent Non-Hodgkin Lymphoma View
Keywords: